No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta-Reference-Cited by-同舟云学术

No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta

Published:2023-09 Issue:3 Volume:79 Page:657-665
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Hollnberger Julius^ORCID,Liu Yang,Xu Simin,Chang Silvia,Martin Ross,Manhas Savrina,Aeschbacher Thomas,Han Bin,Yazdi Tahmineh,May Lindsey,Han Dong,Shornikov Alex,Flaherty John,Manuilov Dmitry,Suri Vithika,Asselah Tarik,Lampertico Pietro,Wedemeyer Heiner,Aleman Soo^ORCID,Richards Christopher,Mateo Roberto^ORCID,Maiorova Evguenia,Cihlar Tomas,Mo Hongmei,Urban Stephan

Funder

Deutsches Zentrum für Infektionsforschung

Gilead Sciences

Publisher

Elsevier BV

Subject

Hepatology

Reference36 articles.

1. Hepatitis D: thirty years after;Rizzetto;J Hepatol,2009

2. Role of the large hepatitis B virus envelope protein in infectivity of the hepatitis delta virion;Sureau;J Virol,1993

3. Hepatitis D virus replication;Taylor;Cold Spring Harb Perspect Med,2015

4. Sodium taurocholate co-transporting polypeptide is a functional receptor for human hepatitis B and D virus;Yan;Elife,2012

5. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes;Ni;Gastroenterology,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virological markers for clinical trials in chronic viral hepatitis;JHEP Reports;2024-09

2. Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D;New England Journal of Medicine;2024-07-11

3. Advances in hepatitis delta research: emerging insights and future directions;Sexually Transmitted Infections;2024-06-24

4. Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies;Journal of Hepatology;2024-06

5. Sodium taurocholate cotransporting polypeptide (NTCP) polymorphisms may influence HDV RNA load and early response to bulevirtide;Journal of Hepatology;2024-06